Schoofs H, Daubel N, Schnabellehner S, Grönloh MLB, Palacios Martínez S, Halme A, Marks AM, Jeansson M, Barcos S, Brakebusch C, Benedito R, Engelhardt B, Vestweber D, Gaengel K, Linsenmeier F, Schürmann S, Saharinen P, van Buul JD, Friedrich O, Smith RS, Majda M, Mäkinen T. Dynamic cytoskeletal regulation of cell shape supports resilience of lymphatic endothelium. Nature. 2025 May;641(8062):465-475.
Santio NM, Ganesh K, Kaipainen PP, Halme A, Seyednasrollah F, Arbash E, Hänninen S, Kivelä R, Carpen O, Saharinen P. Endothelial Pim3 kinase protects the vascular barrier during lung metastasis. Nat Commun. 2024 Dec 3;15(1):10514.
Alsaed B, Smolander J, Laitinen H, Lin L, Bobik N, Lahtinen L, Räsänen M, Jansouz S, Peltonen K, Jokinen E, Klievink J, Ganesh K, Ainola M, Sutinen E, Rönty M, Narvi E, Thotakura A, Saharinen P, Mustjoki S, Ilonen I, Haikala HM. Ex vivo modeling of precision immuno-oncology responses in lung cancer. Sci Adv. 2024 Nov;10(44):eadq6830.
Mannion AJ, Zhao H, Zhang Y, von Wright Y, Bergman O, Roy J, Saharinen P, Holmgren L. Regulation of YAP Promotor Accessibility in Endothelial Mechanotransduction. Arterioscler Thromb Vasc Biol. 2024 Mar;44(3):666-689.
Hakanpaa L, Kiss EA, Jacquemet G, Miinalainen I, Lerche M, Guzmán C, Mervaala E, Eklund L, Ivaska J, Saharinen P. Targeting β1-integrin inhibits vascular leakage in endotoxemia. Proc Natl Acad Sci U S A. 2018 Jun 25.
Eklund L, Kangas J, Saharinen P. Angiopoietin-Tie signaling in the cardiovascular and lymphatic systems. Clinical Science. 1:87-103, 2017.
Lampinen A, Virman J, Bono P, Luukkaala T, Sunela K, Kujala P, Saharinen P, Kellokumpu-Lehtinen P-L. Novel angiogenesis markers as long-term prognostic factors in renal cell cancer patients. Clin Genitourinary Cancer, 15:e15-e24, 2017.
Korhonen E#, Lampinen A#, Giri H, Anisimov A, Kim M, Allen B, Fang S, D’Amico G, Sipilä T, Lohela M, Strandin T, Vaheri, Ylä-Herttuala S, Koh GY, McDonald DM, Alitalo K and Saharinen P. Tie1 controls angiopoietin function in vascular remodeling and inflammation. J Clin Invest. August 22, 2016.
Rautiola J#, Lampinen A#, Mirtti T, Ristimäki A, Joensuu H, Bono P, Saharinen P. Association of Angiopoietin-2 and Ki-67 Expression with Vascular Density and Sunitinib Response in Metastatic Renal Cell Carcinoma. PLoS One. 11(4):e0153745, 2016.
Saharinen P, Ivaska J. Blocking integrin inactivation as an anti-angiogenic therapy. EMBO J. 34:1293-5, 2015.
Hakanpaa L, Sipila T, Leppanen VM, Gautam P, Nurmi H, Jacquemet G, Eklund L, Ivaska J, Alitalo K, Saharinen P. Endothelial destabilization by angiopoietin-2 via integrin β1 activation. Nature Commun 6: 5962, 2015.